These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 9665596)
1. Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Kalra S; Cashman NR; Genge A; Arnold DL Neuroreport; 1998 Jun; 9(8):1757-61. PubMed ID: 9665596 [TBL] [Abstract][Full Text] [Related]
2. An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy. Foerster BR; Pomper MG; Callaghan BC; Petrou M; Edden RA; Mohamed MA; Welsh RC; Carlos RC; Barker PB; Feldman EL JAMA Neurol; 2013 Aug; 70(8):1009-16. PubMed ID: 23797905 [TBL] [Abstract][Full Text] [Related]
3. Gabapentin therapy for amyotrophic lateral sclerosis: lack of improvement in neuronal integrity shown by MR spectroscopy. Kalra S; Cashman NR; Caramanos Z; Genge A; Arnold DL AJNR Am J Neuroradiol; 2003 Mar; 24(3):476-80. PubMed ID: 12637300 [TBL] [Abstract][Full Text] [Related]
4. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS. Rooney WD; Miller RG; Gelinas D; Schuff N; Maudsley AA; Weiner MW Neurology; 1998 Jun; 50(6):1800-5. PubMed ID: 9633731 [TBL] [Abstract][Full Text] [Related]
5. A prospective, randomized, placebo-controlled evaluation of corticoneuronal response to intrathecal BDNF therapy in ALS using magnetic resonance spectroscopy: feasibility and results. Kalra S; Genge A; Arnold DL Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Apr; 4(1):22-6. PubMed ID: 12745614 [TBL] [Abstract][Full Text] [Related]
6. Effect of creatine supplementation on metabolite levels in ALS motor cortices. Vielhaber S; Kaufmann J; Kanowski M; Sailer M; Feistner H; Tempelmann C; Elger CE; Heinze HJ; Kunz WS Exp Neurol; 2001 Dec; 172(2):377-82. PubMed ID: 11716561 [TBL] [Abstract][Full Text] [Related]
7. Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study. Rule RR; Suhy J; Schuff N; Gelinas DF; Miller RG; Weiner MW Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5(3):141-9. PubMed ID: 15512902 [TBL] [Abstract][Full Text] [Related]
8. Progressive Neurochemical Abnormalities in Cognitive and Motor Subgroups of Amyotrophic Lateral Sclerosis: A Prospective Multicenter Study. Ta D; Ishaque A; Srivastava O; Hanstock C; Seres P; Eurich DT; Luk C; Briemberg H; Frayne R; Genge AL; Graham SJ; Korngut L; Zinman L; Kalra S Neurology; 2021 Aug; 97(8):e803-e813. PubMed ID: 34426551 [TBL] [Abstract][Full Text] [Related]
9. Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis. Abe K; Takanashi M; Watanabe Y; Tanaka H; Fujita N; Hirabuki N; Yanagihara T Neuroradiology; 2001 Jul; 43(7):537-41. PubMed ID: 11512581 [TBL] [Abstract][Full Text] [Related]
10. A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings. Ellis CM; Simmons A; Andrews C; Dawson JM; Williams SC; Leigh PN Neurology; 1998 Oct; 51(4):1104-9. PubMed ID: 9781537 [TBL] [Abstract][Full Text] [Related]
11. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Pohl C; Block W; Karitzky J; Träber F; Schmidt S; Grothe C; Lamerichs R; Schild H; Klockgether T Arch Neurol; 2001 May; 58(5):729-35. PubMed ID: 11346367 [TBL] [Abstract][Full Text] [Related]
12. A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results. Saccà F; Quarantelli M; Rinaldi C; Tucci T; Piro R; Perrotta G; Carotenuto B; Marsili A; Palma V; De Michele G; Brunetti A; Brescia Morra V; Filla A; Salvatore M J Neurol; 2012 Jan; 259(1):132-8. PubMed ID: 21706151 [TBL] [Abstract][Full Text] [Related]
13. Detecting neuronal dysfunction of hand motor cortex in ALS: A MRSI study. Wang Y; Li X; Chen W; Wang Z; Xu Y; Luo J; Lin H; Sun G Somatosens Mot Res; 2017 Mar; 34(1):15-20. PubMed ID: 28114839 [TBL] [Abstract][Full Text] [Related]
14. Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis. Atassi N; Xu M; Triantafyllou C; Keil B; Lawson R; Cernasov P; Ratti E; Long CJ; Paganoni S; Murphy A; Salibi N; Seethamraju R; Rosen B; Ratai EM PLoS One; 2017; 12(5):e0177680. PubMed ID: 28498852 [TBL] [Abstract][Full Text] [Related]
15. Hippocampal N-acetylaspartate concentration and response to riluzole in generalized anxiety disorder. Mathew SJ; Price RB; Mao X; Smith EL; Coplan JD; Charney DS; Shungu DC Biol Psychiatry; 2008 May; 63(9):891-8. PubMed ID: 18028881 [TBL] [Abstract][Full Text] [Related]
16. Riluzole does not have an acute effect on motor thresholds and the intracortical excitability in amyotrophic lateral sclerosis. Sommer M; Tergau F; Wischer S; Reimers CD; Beuche W; Paulus W J Neurol; 1999 Nov; 246 Suppl 3():III22-6. PubMed ID: 10631657 [TBL] [Abstract][Full Text] [Related]
17. β-N-methylamino-l-alanine causes neurological and pathological phenotypes mimicking Amyotrophic Lateral Sclerosis (ALS): the first step towards an experimental model for sporadic ALS. de Munck E; Muñoz-Sáez E; Miguel BG; Solas MT; Ojeda I; Martínez A; Gil C; Arahuetes RM Environ Toxicol Pharmacol; 2013 Sep; 36(2):243-255. PubMed ID: 23688553 [TBL] [Abstract][Full Text] [Related]
18. Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI. Suhy J; Miller RG; Rule R; Schuff N; Licht J; Dronsky V; Gelinas D; Maudsley AA; Weiner MW Neurology; 2002 Mar; 58(5):773-9. PubMed ID: 11889242 [TBL] [Abstract][Full Text] [Related]